Good day, everyone and welcome to Pfizer’s Analyst and Investor Call to Review Oncology Business and ASCO Data Presentations. Today’s call is being recorded. At this time, I would like to turn the ...
Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Pfizer stock (NYSE: PFE) lost about 5% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli Lilly ...
Pfizer is still trading at a price we saw back in 2000. For once, it shows several drugs in its pipeline. Can you forgive a stock that failed you? Is it time to forget? Forget that Pfizer (NYSE:PFE), ...
In the latest trading session, Pfizer (PFE) closed at $23.60, marking a -2.03% move from the previous day. This change lagged the S&P 500's daily loss of 0.5%. Meanwhile, the Dow lost 0.38%, and the ...
Investors in Pfizer Inc (Symbol: PFE) saw new options begin trading today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback